Endovascular Today - Latest News http://evtoday.com/ The latest news stories from Endovascular Today. en-us Wed, 21 Feb 2018 14:13:54 GMT Wed, 21 Feb 2018 14:13:54 GMT BMCToday FDA Clears Corindus' CorPath GRX System in Peripheral Vascular Interventions http://evtoday.com/2018/02/20/fda-clears-corindus-corpath-grx-system-in-peripheral-vascular-interventions February 20, 2018 -- Corindus Vascular Robotics, Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration for use of the company's CorPath GRX system in peripheral vascular interventions (PVIs). The CorPath GRX system broadens the capabilities of the CorPath robotic technology platfo... Tue, 20 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/20/fda-clears-corindus-corpath-grx-system-in-peripheral-vascular-interventions Three Rivers Medical's Rio Embolization Coil System Receives CE Mark Approval http://evtoday.com/2018/02/20/three-rivers-medicals-rio-embolization-coil-system-receives-ce-mark-approval February 20, 2018-Three Rivers Medical, Inc. announced that it has received CE Mark approval for the Rio embolization coil system, which is indicated for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulas. The device is als... Tue, 20 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/20/three-rivers-medicals-rio-embolization-coil-system-receives-ce-mark-approval Cook Medical Announces Realignment in Organizational Structure http://evtoday.com/2018/02/20/cook-medical-announces-realignment-in-organizational-structure February 20, 2018 -- Cook Medical announced it has initiated large-scale changes aimed at simplifying its organizational structure, including the realignment of its core business units. Specifically, Cook will merge its existing 10 strategic business units into two large divisions: Vascular and MedSurg. The Vascular divi... Tue, 20 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/20/cook-medical-announces-realignment-in-organizational-structure Perflow Medical Announces Financing to Support Cerebral Aneurysm Technology; Progress With Stroke Platform http://evtoday.com/2018/02/15/perflow-medical-announces-financing-to-support-cerebral-aneurysm-technology-progress-with-stroke-platform February 15, 2018 -- Perflow Medical has announced the closing of $12 million in financing aimed at supporting commercialization of its Stream Net device in Europe and other countries, as well as for submission of 510(k) review in the United States. The funding will also serve to support development of Perflow's Cerebra... Thu, 15 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/15/perflow-medical-announces-financing-to-support-cerebral-aneurysm-technology-progress-with-stroke-platform Stryker's Trevo Retriever Now Indicated for Treating Stroke Up to 24 Hours From Symptom Onset http://evtoday.com/2018/02/15/strykers-trevo-retriever-indicated-for-treating-stroke-up-to-24-hours-from-symptom-onset February 15, 2018 -- Stryker has announced that its Trevo Retriever device has received an expanded indication from the US Food and Drug Administration (FDA) as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from onset. According to Stryker, the Trevo Retriever is the first thrombec... Thu, 15 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/15/strykers-trevo-retriever-indicated-for-treating-stroke-up-to-24-hours-from-symptom-onset First Postmarket Cases Performed Using Extended-Length Diamondback 360 for Radial PAD Atherectomy http://evtoday.com/2018/02/14/first-postmarket-cases-performed-using-diamondback-360-for-radial-pad-atherectomy February 14, 2018 -- Cardiovascular Systems, Inc. (CSI) announced that the first radial access cases were performed using its US Food and Drug Administration -- cleared extended-length Diamondback 360 peripheral orbital atherectomy system (OAS). The cases were led by Mahir Elder, MD, at Detroit Medical Center Heart Hospital... Wed, 14 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/14/first-postmarket-cases-performed-using-diamondback-360-for-radial-pad-atherectomy SVS, AVF Announce Agreement Toward Future Collaborative Efforts http://evtoday.com/2018/02/14/svs-avf-announce-agreement-toward-future-collaborative-efforts February 14, 2018 -- The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) jointly announced an agreement laying the groundwork for future collaboration. The organizations aim to pool their efforts in areas such as advocacy, education, and research to ensure the highest quality of care for patients with... Wed, 14 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/14/svs-avf-announce-agreement-toward-future-collaborative-efforts FDA Approves Marketing of Viz.ai's Stroke Identification Software Application http://evtoday.com/2018/02/13/fda-approves-marketing-of-vizais-stroke-identification-software-application February 13, 2018 -- The US Food and Drug Administration (FDA) announced that it has permitted marketing of Viz.ai’s Contact application, a clinical decision support software designed to analyze CT results that may notify providers of a potential stroke in their patients. The Viz.ai Contact application is a compute... Tue, 13 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/13/fda-approves-marketing-of-vizais-stroke-identification-software-application Terumo Invests £33 Million Into Vascutek Expansion http://evtoday.com/2018/02/12/terumo-invests-33-million-into-vascutek-expansion February 12, 2018 -- Terumo Corporation has announced a £33 million investment into subsidiary Vascutek Ltd. with a goal of driving further growth for the Scotland-based vascular graft manufacturer. The investment will support expanding Vascutek's headquarters and manufacturing facilities, including the additio... Mon, 12 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/12/terumo-invests-33-million-into-vascutek-expansion Twelve-Month Data Presented From Global Lutonix DCB BTK Registry http://evtoday.com/2018/02/07/twelve-month-data-presented-from-global-lutonix-dcb-btk-registry February 7, 2018 -- Michael K.W. Lichtenberg, MD, presented 12-month interim outcomes from the global Lutonix drug-coated balloon (DCB) below-the-knee (BTK) registry study at LINC 2018, the Leipzig Interventional Course held January 30 to February 2 in Leipzig, Germany. The prospective, multicenter, single-arm, real-worl... Wed, 7 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/07/twelve-month-data-presented-from-global-lutonix-dcb-btk-registry Findings From Meta-Analysis Presented for TVA Medical's everlinQ endoAVF System http://evtoday.com/2018/02/07/findings-from-meta-analysis-presented-for-tva-medicals-everlinq-endoavf-system February 7, 2018 -- TVA Medical, Inc. announced the presentation of an international meta-analysis of clinical experience in patients who received the company's everlinQ endovascular arteriovenous fistula (endoAVF) for hemodialysis access. The study analyzed data from 236 patients with end-stage renal disease (ESRD) at ... Wed, 7 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/07/findings-from-meta-analysis-presented-for-tva-medicals-everlinq-endoavf-system Final 24-Month CONSEQUENT Data Presented for B. Braun's SeQuent Please OTW DCB http://evtoday.com/2018/02/07/final-24-month-consequent-data-presented-for-bbrauns-sequent-please-otw-dcb February 7, 2018 -- Final angiographic and clinical 24-month results of the CONSEQUENT trial were presented by Professor Thomas Albrecht, MD, at LINC 2018, the Leipzig Interventional Course held January 30 to February 2 in Leipzig, Germany. Prof. Albrecht stated that the objective of CONSEQUENT is to assess the safety an... Wed, 7 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/07/final-24-month-consequent-data-presented-for-bbrauns-sequent-please-otw-dcb Cagent Vascular Announces Results From the PRELUDE Study http://evtoday.com/2018/02/07/cagent-vascular-announces-results-from-the-prelude-study February 7, 2018 -- Cagent Vascular announced that 30-day results and preliminary 6-month data from the company's PRELUDE study were presented by Principal Investigator Andrew Holden, MBChB, at LINC 2018, the Leipzig Interventional Course held January 30 to February 2 in Leipzig, Germany. PRELUDE is evaluating the sa... Wed, 7 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/07/cagent-vascular-announces-results-from-the-prelude-study Long-Term Results Presented From OPTALYSE PE Trial of Ekos Therapy For Pulmonary Embolism http://evtoday.com/2018/02/06/long-term-results-presented-from-optalyse-pe-trial-of-ekos-therapy-for-pulmonary-embolism February 6, 2018 -- BTG plc announced that 1-year results from the OPTALYSE PE trial were presented at ISET, the annual International Symposium on Endovascular Therapy held February 3 -- 7 in Hollywood, Florida. The trial is evaluating treatment of pulmonary embolism (PE) with the company's Ekos EkoSonic endovascular... Tue, 6 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/06/long-term-results-presented-from-optalyse-pe-trial-of-ekos-therapy-for-pulmonary-embolism Teleflex Launches Next-Generation Versions of 0.035-Inch Snares for Peripheral Procedures http://evtoday.com/2018/02/05/teleflex-launches-next-generation-versions-of-0035-inch-snares-for-peripheral-procedures February 5, 2018 -- Teleflex announced US Food and Drug Administration 510(k) clearance and the United States commercial launch of new versions of the company's Expro Elite and Sympro Elite snares for manipulating interventional devices in peripheral procedures. The devices are next-generation versions of the 0.035-inch... Mon, 5 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/05/teleflex-launches-next-generation-versions-of-0035-inch-snares-for-peripheral-procedures Enrollment Completed in ELEVATE IDE Study of Endologix's Alto EVAR System http://evtoday.com/2018/02/05/enrollment-completed-in-elevate-ide-study-of-endologixs-alto-evar-system February 5, 2018 -- Endologix announced the completion of enrollment in the ELEVATE investigational device exemption (IDE) clinical study. The objective of the 75-patient study is to evaluate the safety and effectiveness of the company's Alto abdominal stent graft system for endovascular aneurysm repair (EVAR) of infrar... Mon, 5 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/05/enrollment-completed-in-elevate-ide-study-of-endologixs-alto-evar-system Veryan Submits BioMimics 3D Stent for FDA Approval http://evtoday.com/2018/02/01/veryan-submits-biomimics-3d-stent-for-fda-approval February 1, 2018 -- Veryan Medical announced it has submitted a premarket approval (PMA) application for the BioMimics three-dimensional vascular stent system to the US Food & Drug Administration (FDA). The PMA application is supported by the 12-month interim safety and effectiveness results from the company's pi... Thu, 1 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/01/veryan-submits-biomimics-3d-stent-for-fda-approval Presentations Support Medtronic's In.Pact Admiral Drug-Coated Balloon http://evtoday.com/2018/02/01/presentations-support-medtronics-inpact-admiral-drug-coated-balloon January 30, 2018 -- Medtronic announced that clinical data supporting the company's In.Pact Admiral drug-coated balloon (DCB) were presented at LINC 2018: the Leipzig Interventional Course held January 30 to February 2 in Leipzig, Germany. The presentations included the 2-year results from the MDT-2113 study (IN.PACT SF... Thu, 1 Feb 2018 04:00:00 GMT http://evtoday.com/2018/02/01/presentations-support-medtronics-inpact-admiral-drug-coated-balloon Biotronik's Technology Evaluated for Reduction of Metal Burden in SFA Treatment http://evtoday.com/2018/01/31/biotroniks-technology-evaluated-for-reduction-of-metal-burden-in-sfa-treatment January 31, 2018 -- Biotronik announced that data demonstrating that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates were presented during a company-sponsored symposium chaired by Jos van den Berg, MD, at LINC 2018: the Leipzig Interventional Course, held January 3... Wed, 31 Jan 2018 04:00:00 GMT http://evtoday.com/2018/01/31/biotroniks-technology-evaluated-for-reduction-of-metal-burden-in-sfa-treatment Med Alliance's SELUTION FIM Study Achieves Primary Endpoint http://evtoday.com/2018/01/31/med-alliances-selution-fim-study-achieves-primary-endpoint January 31, 2018 -- Med Alliance announced that primary endpoint data from the first-in-man (FIM) study of the company's Selution sirolimus-coated balloon were presented by Principal Investigator Professor Thomas Zeller, MD, at LINC 2018, the Leipzig Interventional Course held January 30 to February 2 in Leipzig, German... Wed, 31 Jan 2018 04:00:00 GMT http://evtoday.com/2018/01/31/med-alliances-selution-fim-study-achieves-primary-endpoint